+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Gypenoside XLIX

BP0693
94987-08-3
98%
Phytopurify
Gypenoside XLIX, a naturally occurring gynosaponin, inhibits NF-kappaB activation via a PPAR-alpha-dependent pathway, it may treat inflammatory and cardiovascular diseases, including atherosclerosis.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0693-20mg 20mg
BP0693-100mg 100mg
BP0693-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

NOS3 AMPK RELA TNF NOS2 PPARG SREBF1 PTGS2 IL6 IL1B IRS1 SLC2A4 PPARA
AMPK RELA TNF NOS2 PPARG SREBF1 PTGS2 IL6 IL1B IRS1 SLC2A4 MET PPARA
RELA TNF NOS2 PTGS2 IL1B PPARA

Product drug property prediction parameters

  • 333.6700

  • 1.9652

  • 1.9649

  • .1344

  • .5090

  • .1803

  • Low

  • 72.3074

  • 6.8901

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • Yes